Victory Capital Management
TCON

Victory Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Victory Capital Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-82
Closed -$2K – 3405
2020
Q1 		$2K Buy
+82
New +$4.76K ﹤0.01% 3697
2019
Q4 		– Sell
-23
Closed -$2K – 3392
2019
Q3 		$2K Buy
+23
New +$2.36K ﹤0.01% 3661

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Victory Capital Management's TCON Position: Q2 2020 in Review

Victory Capital Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2020, closing a stake of 82 shares — an estimated $2K sold.

Victory Capital Management first reported a position in TCON in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q1 2020. 18 funds tracked by Wall St. Rank hold TCON as of Q2 2020.

  • Victory Capital Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 82 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $2K.
  • Victory Capital Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q1 2020.
  • 18 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.